Dr. Muzammil Shaikh

Dr. Muzammil Shaikh

Director

23 Years of Experience

Medical Oncologist

MD, MBBS, DM, DNB

Reg. No.:2001031310, Maharashtra Medical Council

Nanavati-Max Super Speciality Hospital, Mumbai

English

Consultation Fee ₹

Book an Appointment

About Dr. Muzammil Shaikh

  • Dr. Muzammil Shaikh is a renowned and skilled medical oncologist with 23 years of experience in the field.
  • His clinical interests include Geriatric Oncology, Carcinoma Ovary, Carcinoma Lung, Bone & Soft tissue Sarcomas, Precision & Molecular Oncology, Hematolymphoid Malignancies, Head & Neck Cancers, Carcinoma Breast, Gastro-Intestinal & Hepatobiliary Cancers, Genito-Urinary Cancers, Palliative Care, etc.
  • He offers treatments like Adrenal Cancer Treatment, Metastatic Tumors Treatment, Bile Duct Cancer Treatment, Chemotherapy, etc.
  • He has done an MBBS from GrantGovt. Medical College & Sir J.J. Hospital University of Mumbai in 2001. He did his M.D. in Medicine from Seth G.S. Medical College & KEM Hospital, University of Mumbai in 2006. 
  • He pursued a D.M. in Medical Oncology from the Gujarat Cancer & Research Institute in 2010. He earned his DNB in Medical Oncology from the National Board, New Delhi 2011.
  • He is an active member of the Indian Co-operative Oncology Network (ICON), Indian Musculo Skeletal, Oncology Study Group (IMSOS), European Society of Medical Oncology (ESMO), Mumbai Hematology Group (MHG) and the Indian Medical Association (IMA). He has been active in cancer research, authored many textbooks, and published research papers in national and international journals.
  • He has received a Gold Medal in Medical Oncology at Gujarat University.

Book Your Appointment With Dr. Muzammil Shaikh

Get a Treatment Plan Within 1 Hour

Education

  • MBBS, Grant Govt. Medical College and Sir J.J. Hospital University of Mumbai in 2001
  • M.D. in Internal Medicine from Seth G.S. Medical College & KEM Hospital, University of Mumbai, 2006
  • D.M. in Medical Oncology from The Gujarat Cancer & Research Institute, 2010
  • DNB in Medical Oncology, National Board, New Delhi, 2011

Past Experience

  • Observership in M.D. Anderson Cancer Centre, Houston, Texas, USA, 2013   
  • Consultant Medical Oncologist, P.D. Hinduja National Hospital & MRC, Mumbai
  • Jr. Consultant, P.D. Hinduja National Hospital & Medical Research Centre, Mumbai
  • Associate Consultant, P.D. Hinduja National Hospital & Medical Research Centre, Mumbai, 2012   
  • Senior Registrar, The Gujarat Cancer & Research Institute & Cancer Center, Gujarat, 2010 

Awards

  • Gold Medal in Medical Oncology at Gujarat University

Associations/Membership

  • Indian Co-operative Oncology Network (ICON)
  • Indian Oncology Study Group (IOSG)
  • European Society of Medical Oncology (ESMO)
  • Mumbai Hematology Group (MHG)
  • Indian Medical Association (IMA)

Paper Published

  • Tumor markers in gynecological malignancies. Dr Shaikh Muzammil, Dr Asha Kapadia. Current Opinion in Obstetrics & Gynecology -2012” (In publication by Jaypee India)  July 2012
  • Treatment outcome for Germ cell Tumor (GCT) Brain: Experience from a Single Centre. V Kanan, B.K. Misra,A Kapadia, Dr. Sachin Almel, Dr Muzammil  Shaikh, Dr Milind Sankhe, Dr Ketan Desai, Dr Vivek Anand, Dr Aarthi Kannan, Hinduja hospital, Mumbai 
  • Breast – Prevalence, Screening, Risk factors, Prevention, Effect of HT". Dr Shaikh Muzammil, Dr Asha Kapadia.  Clinical Practice Guidelines on Menopause (In press). July 2012
  • A Single-Institution Retrospective Analysis of Outcomes for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy: Kannan Venkatesan, Vivek Anand, Ranjeet Bajpai, Rohit Santosh Kabre, Asha Kapadia, Sachin Almel, Muzammil Shaikh, Vinay Babu, Ajay Kolse, Ganesh Nagrajan, Murad Lala, Smruti krishna, P Jagannath, Sudesh Deshpande

Field of Expertise

  • CAR T-Cell Therapy
  • Chemotherapy
  • Endometrial Biopsy
  • Fine Needle Aspiration
  • Hormone Therapy
  • Immunotherapy
  • Microsurgical Tumor Removal
  • Minimally Invasive Cancer Surgery
  • Mohs Surgery
  • Oncological Surgery
  • Ovarian Biopsy
  • Pap Smear
  • Radiation Therapy
  • Acute Lymphocytic Leukemia
  • Adnexal Tumor
  • Adult Hodgkins Lymphoma
  • Astrocytoma
  • Atypical Hyperplasia
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Basal Cell Carcinoma (BCC)
  • Benign Bone Tumors
  • Benign Hematology
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Bone Cancer
  • Brain Stem Glioma
  • Breast Cancer
  • Breast Cancer During Pregnancy
  • Breast Cancer Recurrence
  • Carcinoid Syndrome
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Childhood Acute Lymphoblastic Leukemia
  • Chordomas
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous T-Cell Lymphoma
  • Cyclic Neutropenia
  • Ductal Carcinoma in Situ (DCIS)
  • Elevated PSA (Prostate-Specific Antigen) Level
  • Eosinophilia
  • Esophageal Cancer
  • Esophagectomy
  • Estrogen Dependent Cancers
  • Extrahepatic Bile Duct Cancer
  • Fallopian Tube Cancer
  • Familial Adenomatous Polyposis (FAP)
  • Familial Adenomatous Polyposis (FAP): Inherited
  • Fanconi Anemia (FA)
  • Free Flap Surgery for Treating Osteoradionecrosis
  • Gangrene
  • Giant Cell Tumor
  • Gliomas Tumors
  • Head and Neck Cancer
  • Heart Cancer
  • Hemangiopericytoma
  • Hemophilia
  • Hereditary Non-polyposis Colorectal Cancer (HNPCC)
  • Hodgkin Lymphoma
  • Hurthle Cell Carcinoma
  • Hypopharyngeal Cancer
  • Malignant Peripheral Nerve Sheath Tumor (MPNST)
  • Mediastinal Teratoma
  • Nasal Cancer
  • Nasopharyngeal Angiofibroma
  • Olfactory Neuroblastoma
  • Ophthalmic Cancer
  • Optic Nerve Glioma
  • Paranasal Tumor
  • Pediatric Spinal Tumor
  • Pigmented Villonodular Synovitis (PVNS)
  • Polycythemia Vera
  • Sacrococcygeal Teratoma (SCT)
  • Tarlov Cysts